Speaker Profile

Ph.D., CEO, Travera
Biography

Prior to founding Travera, Dr. Reid was the founding Chairman, President and CEO of Complete Genomics (NASDAQ:GNOM), a leading developer of whole human genome DNA sequencing technologies and services. He was also Executive Chairman of Genos Research, a consumer genomics company he spun off from Complete Genomics. Prior to Complete Genomics he founded two enterprise software companies: Eloquent (NASDAQ:ELOQ), an internet video company, and Verity (NASDAQ:VRTY), an enterprise search engine company. Dr. Reid is on the Visiting Committee of the Biological Engineering Department at the Massachusetts Institute of Technology (MIT), a member of the MIT Corporation Development Committee, and an advisor to Warburg Pincus. He earned a S.B. in Physics from MIT, an MBA from the Harvard Business School, and a Ph.D. in Management Science and Engineering from Stanford University.

Clinical Dx Showcase: Travera
Travera is developing the first universal therapy-directing biomarker for personalized medicine for cancer.

A New Biomarker For Personalizing Cancer Therapies
Travera uses a novel mass-based biophysical measurement of the ex vivo response of individual cancer cells to cancer drugs to predict patient response. We completed a multiple myeloma pilot study at DFCI and are launching a 100-patient clinical study.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

You have Successfully Subscribed!